{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:23:58Z","timestamp":1784330638353,"version":"3.55.0"},"reference-count":80,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.3272","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T22:05:16Z","timestamp":1457993116000},"page":"567-572","source":"Crossref","is-referenced-by-count":26,"title":["Meningococcemia in Adults: A Review of the Literature"],"prefix":"10.2169","volume":"55","author":[{"given":"Shimon","family":"Takada","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Nara City Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tohoku University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Inoue","sequence":"additional","affiliation":[{"name":"Urasoe General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Hyogo Prefectural Amagasaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Hadano","sequence":"additional","affiliation":[{"name":"Rakuwakai Otowa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"National Medical Clinic, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Morino","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tohoku University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Tokyo Joto Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Caugant DA. Genetics and evolution of <i>Neisseria meningitidis<\/i>: importance for the epidemiology of meningococcal disease. Infect Genet Evol 8: 558-565, 2008.","DOI":"10.1016\/j.meegid.2008.04.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Buysse CM, Raat H, Hazelzet JA, Hop WC, Maliepaard M, Joosten KF. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge. Crit Care Med 36: 596-602, 2008.","DOI":"10.1097\/01.CCM.0000299740.65484.CA"},{"key":"3","unstructured":"3. Vieusseux M. M&eacute;moire sur la maladie qui a regn&eacute; a Gen&ecirc;ve au printemps de 1805. J Med Chir Pharm 11: 163-182, 1805 (in French)."},{"key":"4","unstructured":"4. Weichselbaum A. Ueber die Aetiologie der akuten Meningitis cerebrospinalis. Fortschr Med 5: 573-583, 1887 (in German)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rosenstein NE, Bradley BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 344: 1378-1388, 2001.","DOI":"10.1056\/NEJM200105033441807"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 106: 505-510, 1998.","DOI":"10.1111\/j.1699-0463.1998.tb01379.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vienne P, Ducos-Galand M, Guiyoule A, et al. The role of particular strains of <i>Neisseria meningitidis<\/i> in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis 37: 1639-1642, 2003.","DOI":"10.1086\/379719"},{"key":"8","unstructured":"8. Garc&iacute;a-Porr&uacute;a C, Gonz&aacute;lez-Gay MA. Bacterial infection presenting as cutaneous vasculitis in adults. Clin Exp Rheumatol 17: 471-473, 1999."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Marotto MS, Marotto PC, Sztajnbok J, et al. Outcome of acute renal failure in meningococcemia. Ren Fail 19: 807-810, 1997.","DOI":"10.3109\/08860229709037221"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Giardina PC, Weiss JA, Gibson BW, Apicella MA. Isolation and analysis of radiolabeled meningococcal endotoxin. Methods Mol Med 67: 441-458, 2001.","DOI":"10.1385\/1-59259-149-3:441"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and <i>Neisseria meningitides<\/i>. Lancet 369: 2196-2210, 2007.","DOI":"10.1016\/S0140-6736(07)61016-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. O'Brien JA, Caro JJ, Getsios D. Managing meningococcal disease in the United States: hospital case characteristics and costs by age. Value Health 9: 236-243, 2006.","DOI":"10.1111\/j.1524-4733.2006.00113.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Olc&eacute;n P, Barr J, Kjellander J. Meningitis and bacteremia due to <i>Neisseria meningitidis<\/i>: clinical and laboratory findings in 69 cases from Orebro county, 1965 to 1977. Scand J Infect Dis 11: 111-119, 1979.","DOI":"10.3109\/inf.1979.11.issue-2.03"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gil-Prieto R, Garc&iacute;a-Garc&iacute;a L, Alvaro-Meca A, Gonz&aacute;lez-Escalada A, Viguera Ester P, Gil De Miguel A. The burden of hospitalizations for meningococcal infection in Spain (1997-2008). Vaccine 29: 5765-5770, 2011.","DOI":"10.1016\/j.vaccine.2011.05.089"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Halperin SA, Bettinger JA, Greenwood B, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine 30 (Suppl 2): B26-B36, 2012.","DOI":"10.1016\/j.vaccine.2011.12.032"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gagneux S, Hodgson A, Ehrhard I, et al. Microheterogeneity of serogroup A (subgroup III) <i>Neisseria meningitidis<\/i> during an outbreak in northern Ghana. Trop Med Int Health 5: 280-287, 2000.","DOI":"10.1046\/j.1365-3156.2000.00550.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Djibo S, Nicolas P, Alonso JM, et al. Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Tropical Med Int Health 8: 1118-1123, 2003.","DOI":"10.1046\/j.1360-2276.2003.01126.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Butler D. Vaccine offers meningitis hope. Nature 468: 143, 2010.","DOI":"10.1038\/468143a"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Massenet D, Vohod D, Hamadicko H, Caugant DA. Epidemic meningococcal meningitis, Cameroon. Emerg Infect Dis 17: 2070-2072, 2011.","DOI":"10.3201\/eid1711.110468"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Molesworth AM, Cuevas LE, Connor SJ, Morse AP, Thomson MC. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis 9: 1287-1293, 2003.","DOI":"10.3201\/eid0910.030182"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Caugant DA, Nicolas P. Molecular surveillance of meningococcal meningitis in Africa. Vaccine 25 (Suppl 1): A8-A11, 2007.","DOI":"10.1016\/j.vaccine.2007.04.033"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Diermayer M, Hedberg K, Hoesly F, et al. Epidemic serogroup B meningococcal disease in Oregon. JAMA 281: 1493-1497, 1999.","DOI":"10.1001\/jama.281.16.1493"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Paret G, Keller N, Barzilai A, et al. Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control. Infection 27: 261-264, 1999.","DOI":"10.1007\/s150100050025"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. von Gottberg A, du Plessis M, Cohen C, et al. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 46: 377-386, 2008.","DOI":"10.1086\/525260"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Koumar&eacute; B, Ouedraogo-Traor&eacute; R, Sanou I, et al. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. Vaccine 25 (Suppl 1): A37-A41, 2007.","DOI":"10.1016\/j.vaccine.2007.04.038"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nathan N, Rose AM, Legros D, et al. Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis 13: 920-923, 2007.","DOI":"10.3201\/eid1306.060940"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Racoosin JA, Whitney CG, Conover CS, Diaz PS. Serogroup Y meningococcal disease in Chicago, 1991-1997. JAMA 280: 2094-2098, 1998.","DOI":"10.1001\/jama.280.24.2094"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Materu S, Cox HS, Isaakidis P, Baruani B, Ogaro T, Caugant DA. Serogroup X in meningococcal disease, Western Kenya. Emerg Infect Dis 13: 944-945, 2007.","DOI":"10.3201\/eid1306.070042"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 180: 1894-1901, 1999.","DOI":"10.1086\/315158"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Garty BZ, Nitzan M, Danon YL. Systemic meningococcal infections in patients with acquired complement deficiency. Pediatr Allergy Immunol 4: 6-9, 1993.","DOI":"10.1111\/j.1399-3038.1993.tb00057.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med 123: 937-940, 1995.","DOI":"10.7326\/0003-4819-123-12-199512150-00007"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Nielsen HE, Koch C, Mansa B, Magnussen P, Bergmann OJ. Complement and immunoglobulin studies in 15 cases of chronic meningococcemia: properdin deficiency and hypoimmunoglobulinemia. Scand J Infect Dis 22: 31-36, 1990.","DOI":"10.3109\/00365549009023116"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wenger J. Toward control of meningococcal disease reducing risk in college students. JAMA 286: 720-721, 2001.","DOI":"10.1001\/jama.286.6.720"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Haburchak DR. Sporadic military meningococcal disease: a diversity of presentations. South Med J 74: 153-156, 1981.","DOI":"10.1097\/00007611-198102000-00007"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Coen PG, Tully J, Stuart JM, Ashby D, Viner RM, Booy R. Is it exposure to cigarette smoke or to smokers which increases the risk of meningococcal disease in teenagers? Int J Epidemiol 35: 330-336, 2006.","DOI":"10.1093\/ije\/dyi295"},{"key":"36","unstructured":"36. Duff P. Pathophysiology and management of septic shock. J Reprod Med 24: 109-117, 1980."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Rouphael NG, Stephens DS. <i>Neisseria meningitidis<\/i>: biology, microbiology, and epidemiology. Methods Mol Biol 799: 1-20, 2012.","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tzeng YL, Stephens DS. Epidemiology and pathogenesis of <i>Neisseria meningitidis<\/i>. Microbes Infect 2: 687-700, 2000.","DOI":"10.1016\/S1286-4579(00)00356-7"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Zughaier SM, Tzeng YL, Zimmer SM, Dutta A, Carlson RW, Stephens DS. <i>Neisseria menigitidis<\/i> lipooligosaccharide structure-dependent activation of the macrophage CD15\/Toll-like receptor 4 pathway. Infect Immun 72: 371-380, 2004.","DOI":"10.1128\/IAI.72.1.371-380.2004"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Merz AJ, So M. Attachment of piliated, Opa-and Opc-gonococci and meningococci to epithelial cells elicits cortical actin rearrangements and clustering of tyrosine-phosphorylated proteins. Infect Immun 65: 4341-4349, 1997.","DOI":"10.1128\/IAI.65.10.4341-4349.1997"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Mandrell RE, Griffiss JM, Macher BA. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med 168: 107-126, 1988.","DOI":"10.1084\/jem.168.1.107"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. Methods Mol Biol 799: 21-35, 2012.","DOI":"10.1007\/978-1-61779-346-2_2"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Campbell WN, Joshi M, Sileo D. Osteonecrosis following meningococcemia and disseminated intravascular coagulation in an adult: case report and review. Clin Infect Dis 24: 452-455, 1997.","DOI":"10.1093\/clinids\/24.3.452"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Parmentier L, Garzoni C, Antille C, Kaiser L, Ninet B, Borradori L. Value of a novel <i>Neisseria meningitidis<\/i> specific polymerase chain reaction assay in skin biopsy specimens as a diagnostic tool in chronic meningococcemia. Arch Dermatol 144: 770-773, 2008.","DOI":"10.1001\/archderm.144.6.770"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Schaad UB. Arthritis in disease due to <i>Neisseria meningitidis<\/i>. Rev Infect Dis 2: 880-888, 1980.","DOI":"10.1093\/clinids\/2.6.880"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Guarner J, Paddock CD, Bartlett J, Zaki SR. Adrenal gland hemorrhage in patients with fatal bacterial infections. Mod Pathol 21: 1113-1120, 2008.","DOI":"10.1038\/modpathol.2008.98"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Brandtzaeg P. Pathogenesis and pathophysiology of invasive meningococcal disease. In: Handbook of Meningococcal Disease. Frosch M, Maiden M, Eds. Wiley-VCH Verlag, Weinheim, 2006: 427-480.","DOI":"10.1002\/3527608508.ch21"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF, et al. Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromb Haemost 76: 932-938, 1996.","DOI":"10.1055\/s-0038-1650688"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Guarner J, Greer PW, Whitney A, et al. Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays. Am J Clin Pathol 122: 754-764, 2004.","DOI":"10.1309\/3489075U03LMK9AE"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Harrison OB, Robertson BD, Faust SN, et al. Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by <i>Neisseria meningitidis<\/i> in vivo. Infect Immun 70: 5193-5201, 2002.","DOI":"10.1128\/IAI.70.9.5193-5201.2002"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. van Deuren M, van Dijke BJ, Koopman RJ, et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 306: 1229-1232, 1993.","DOI":"10.1136\/bmj.306.6887.1229"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Vartian CV. Abdominal pain and fever: an unusual presentation of meningococcemia. Clin Infect Dis 29: 1606, 1999.","DOI":"10.1086\/313556"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Hoyne AL, Brown RH. Seven hundred and twenty seven meningococcic cases; an analysis. Ann Intern Med 28: 248-259, 1948.","DOI":"10.7326\/0003-4819-28-2-248"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Arend SM, Lavrijsen AP, Kuijken I, van der Plas RN, Kuijper EJ. Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease. Eur J Clin Microbiol Infect Dis 25: 643-649, 2006.","DOI":"10.1007\/s10096-006-0199-7"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Gray SJ, Trotter CL, Ramsay ME, et al. Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol 55: 887-896, 2006.","DOI":"10.1099\/jmm.0.46288-0"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Bryant PA, Li HY, Zaia A, et al. Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children. J Clin Microbiol 42: 2919-2925, 2004.","DOI":"10.1128\/JCM.42.7.2919-2925.2004"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Staquet P, Lemee L, Verdier E. Detection of <i>Neisseria meningitidis<\/i> DNA from skin lesion biopsy using real-time PCR: usefulness in the aetiological diagnosis of purpura fulminans. Intensive Care Med 33: 1168-1172, 2007.","DOI":"10.1007\/s00134-007-0667-2"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Brandtzaeg P, Ovsteb&oslash;o R, Kierulf P. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis 166: 650-652, 1992.","DOI":"10.1093\/infdis\/166.3.650"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Brandtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159: 195-204, 1989.","DOI":"10.1093\/infdis\/159.2.195"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Brandtzaeg P, Bryn K, Kierulf P, et al. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest 89: 816-823, 1992.","DOI":"10.1172\/JCI115660"},{"key":"61","unstructured":"61. WHO Media centre. Meningococcal meningitis [Internet]. [cited 2014 Jun 12]. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Sprott MS, Kearns AM, Field JM. Penicillin-insensitive <i>Neisseria meningitidis<\/i>. Lancet 1: 1167, 1988.","DOI":"10.1016\/S0140-6736(88)91982-4"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Mendelman PM, Campos J, Chaffin DO, Serfass DA, Smith AL, S&aacute;ez-Nieto JA. Relative penicillin G resistance in <i>Neisseria meningitidis<\/i> and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother 32: 706-709, 1988.","DOI":"10.1128\/AAC.32.5.706"},{"key":"64","unstructured":"64. S&aacute;ez-Nieto JA, Lujan R, Berr&oacute;n S, et al. Epidemiology and molecular basis of penicillin-resistant <i>Neisseria meningitidis<\/i> in Spain: a 5-year history (1985-1989). Clin Infect Dis 14: 394-402, 1992."},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Trotter CL, Fox AJ, Ramsay ME, et al. Fatal outcome from meningococcal disease: an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol 51: 855-860, 2002.","DOI":"10.1099\/0022-1317-51-10-855"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39: 1267-1284, 2004.","DOI":"10.1086\/425368"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Galimand M, Gerbaud G, Guibourdenche M, Riou JY, Courvalin P. High-level chloramphenicol resistance in <i>Neisseria meningitidis<\/i>. N Engl J Med 339: 868-874, 1998.","DOI":"10.1056\/NEJM199809243391302"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Ellis-Pegler R, Galler L, Roberts S, Thomas M, Woodhouse A. Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis 37: 658-662, 2003.","DOI":"10.1086\/377203"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Nathan N, Borel T, Djibo A, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 366: 308-313, 2005.","DOI":"10.1016\/S0140-6736(05)66792-X"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Hedberg ST, Fredlund H, Nicolas P, Caugant DA, Olc&eacute;n P, Unemo M. Antibiotic susceptibility and characteristics of <i>Neisseria meningitidis<\/i> isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives. Antimicrob Agents Chemother 53: 1561-1566, 2009.","DOI":"10.1128\/AAC.00994-08"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Tettelin H, Saunders NJ, Heidelberg J, et al. Complete genome sequence of <i>Neisseria meningitidis<\/i> serogroup B strain MC58. Science 287: 1809-1815, 2000.","DOI":"10.1126\/science.287.5459.1809"},{"key":"72","unstructured":"72. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 (RR-7): 1-21, 2005."},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidal\/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356: 961-967, 2000.","DOI":"10.1016\/S0140-6736(00)02712-4"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Flexner S. The results of the serum treatment in thirteen hundred cases of epidemic meningitis. J Exp Med 17: 553-576, 1913.","DOI":"10.1084\/jem.17.5.553"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Goldacre MJ, Roberts SE, Yeates D. Case fatality rates for meningococcal disease in an English population, 1963-98: database study. BMJ 327: 596-597, 2003.","DOI":"10.1136\/bmj.327.7415.596"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Barquet N, Domingo P, Cayl&agrave; JA, et al. Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA 278: 491-496, 1997.","DOI":"10.1001\/jama.278.6.491"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Gardner P. Clinical practice. Prevention of meningococcal disease. N Engl J Med 355: 1466-1473, 2006.","DOI":"10.1056\/NEJMcp063561"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Block C, Vazquez JA. Antibiotic resistance. In: Handbook of Meningococcal Disease. Frosch M, Maiden M, Eds. Wiley-VCH Verlag, Weinheim, 2006: 53-74.","DOI":"10.1002\/3527608508.ch4"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Wilder-Smith A. Meningococcal disease: risk for international travellers and vaccine strategies. Travel Med Infect Dis 6: 182-186, 2008.","DOI":"10.1016\/j.tmaid.2007.10.002"},{"key":"80","unstructured":"80. CDC. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep 58: 1042-1043, 2009."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/6\/55_55.3272\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T04:19:30Z","timestamp":1600316370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/6\/55_55.3272\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.3272","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}